Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results26

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results18

Views

Views
May 20243
June 20240
July 20240
August 20245
September 20242
October 20243
November 20245
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
United Kingdom1
 

Top cities views

Views
Santa Clara4
Prineville2
Chicago1
Fort Worth1